{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:07:38Z","timestamp":1794269258847,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic foot ulcers are a common complication of poorly controlled diabetes and often become infected, termed diabetic foot infection. There have been numerous studies of the microbiology of diabetic foot infection but no meta-analysis has provided a global overview of these data. This meta-analysis aimed to investigate the prevalence of bacteria isolated from diabetic foot infections using studies of any design which reported diabetic foot infection culture results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Medline, EMBASE, Web of Science and BIOSIS electronic databases were searched for studies published up to 2019 which contained microbiological culture results from at least 10 diabetic foot infection patients. Two authors independently assessed study eligibility and extracted the data. The main outcome was the prevalence of each bacterial genera or species.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 112 studies were included, representing 16,159 patients from which 22,198 microbial isolates were obtained. The organism most commonly identified was\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      , of which 18.0% (95% CI 13.8\u201322.6%; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200993.8% [93.0\u201394.5%]) was MRSA. Other highly prevalent organisms were\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      spp.,\n                      <jats:italic>E. coli<\/jats:italic>\n                      and\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      spp. A correlation was identified between Gross National Income and the prevalence of Gram positive or negative organisms in diabetic foot infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The microbiology of diabetic foot infections is diverse, but\n                      <jats:italic>S. aureus<\/jats:italic>\n                      predominates. The correlation between the prevalence of Gram positive and negative organisms and Gross National Income could reflect differences in healthcare provision and sanitation. This meta-analysis has synthesised multiple datasets to provide a global overview of the microbiology of diabetic foot infections that will help direct the development of novel therapeutics.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06516-7","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T02:02:50Z","timestamp":1628474570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":234,"title":["The microbiology of diabetic foot infections: a meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Katherine E.","family":"Macdonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Boeckh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"issue":"6","key":"6516_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4239\/wjd.v6.i6.850","volume":"6","author":"AT Kharroubi","year":"2015","unstructured":"Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. World J Diab. 2015;6(6):850\u201367.","journal-title":"World J Diab"},{"issue":"2","key":"6516_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217\u201328.","journal-title":"JAMA"},{"key":"6516_CR3","unstructured":"Insight Health Economics. Foot care in diabetes: the human and financial cost [Internet]. 2017 [cited 2021 Aug 7]. http:\/\/www.londonscn.nhs.uk\/wp-content\/uploads\/2017\/04\/dia-foot-care-mtg-kerr-27042017.pdf"},{"issue":"3","key":"6516_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.dsx.2015.04.007","volume":"9","author":"S Noor","year":"2015","unstructured":"Noor S, Zubair M, Ahmad J. Diabetic foot ulcer\u2014a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr Clin Res Rev. 2015;9(3):192\u20139.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"S1","key":"6516_CR5","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1002\/dmrr.3266","volume":"36","author":"NC Schaper","year":"2020","unstructured":"Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diab Metab Res Rev. 2020;36(S1):3266.","journal-title":"Diab Metab Res Rev."},{"issue":"1","key":"6516_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/dme.13537","volume":"35","author":"M Ndosi","year":"2018","unstructured":"Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky BA, Bhogal M, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78\u201388.","journal-title":"Diabet Med"},{"key":"6516_CR7","first-page":"8","volume":"12","author":"S Shettigar","year":"2018","unstructured":"Shettigar S, Shenoy S, Sevitha S, Rao P. Microbiological profile of deep tissue and bone tissue in diabetic foot osteomyelitis. J Clin Diagn Res. 2018;12:8.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"6516_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3947\/ic.2018.50.1.11","volume":"50","author":"KT Kwon","year":"2018","unstructured":"Kwon KT, Armstrong DG. Microbiology and antimicrobial therapy for diabetic foot infections. Infect Chemother. 2018;50(1):11\u201320.","journal-title":"Infect Chemother"},{"issue":"5\u20136","key":"6516_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humic.2017.09.002","volume":"1","author":"J Jneid","year":"2017","unstructured":"Jneid J, Lavigne JP, La Scola B, Cassir N. The diabetic foot microbiota: a review. Hum Microbiome J. 2017;1(5\u20136):1\u20136.","journal-title":"Hum Microbiome J"},{"issue":"3","key":"6516_CR10","first-page":"441","volume":"7","author":"P Shanmugam","year":"2013","unstructured":"Shanmugam P, Susan SL. The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J Clin Diagn Res JCDR. 2013;7(3):441\u20135.","journal-title":"J Clin Diagn Res JCDR."},{"issue":"34","key":"6516_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.anaerobe.2015.03.009","volume":"1","author":"PGP Charles","year":"2015","unstructured":"Charles PGP, U\u00e7kay I, Kressmann B, Emonet S, Lipsky BA. The role of anaerobes in diabetic foot infections. Anaerobe. 2015;1(34):8\u201313.","journal-title":"Anaerobe"},{"key":"6516_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00592-019-01301-0","volume":"56","author":"HJ Stacey","year":"2019","unstructured":"Stacey HJ, Clements CS, Welburn SC, Jones JD. The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis. Acta Diabetol. 2019;56:907.","journal-title":"Acta Diabetol"},{"key":"6516_CR13","first-page":"8","volume":"21","author":"SG Pereira","year":"2017","unstructured":"Pereira SG, Moura J, Carvalho E, Empadinhas N. Microbiota of chronic diabetic wounds: ecology, impact, and potential for innovative treatment strategies. Front Microbiol. 2017;21:8.","journal-title":"Front Microbiol"},{"issue":"1","key":"6516_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","volume":"26","author":"M Malone","year":"2017","unstructured":"Malone M, Bjarnsholt T, McBain AJ, James GA, Stoodley P, Leaper D, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26(1):20\u20135.","journal-title":"J Wound Care"},{"key":"6516_CR15","first-page":"328796","volume":"15","author":"M Anvarinejad","year":"2015","unstructured":"Anvarinejad M, Pouladfar G, Japoni A, Abbasi P, Bolandparvaz S, Satiary Z, et al. Isolation and antibiotic susceptibility of the microorganisms isolated from diabetic foot infections in Nemazee Hospital, Southern Iran. J Pathog. 2015;15:328796.","journal-title":"J Pathog."},{"issue":"8","key":"6516_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1469-0691.2009.03067.x","volume":"16","author":"N Saltoglu","year":"2010","unstructured":"Saltoglu N, Dalkiran A, Tasova Y, Tetiker T, Sert M, Bayram H, et al. Piperacillin\/tazobactam versus imipenem\/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin Microbiol Infect. 2010;16(8):1252\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"6516_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1469-0691.2010.03194.x","volume":"17","author":"O Lesens","year":"2011","unstructured":"Lesens O, Vidal M, Beytout J, Laurichesse H, Desbiez F, Tauveron I, et al. Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis. Clin Microbiol Infect. 2011;17(2):285\u201391.","journal-title":"Clin Microbiol Infect"},{"issue":"15","key":"6516_CR18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"key":"6516_CR19","unstructured":"The World Bank. World Bank Country and Lending Groups [Internet]. 2018 [cited 2021 Aug 7]. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519"},{"key":"6516_CR20","unstructured":"The Joanna Briggs Institute. Critical appraisal tools - JBI [Internet]. [cited 2021 Aug 7]. https:\/\/jbi.global\/critical-appraisal-tools"},{"issue":"7414","key":"6516_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"6516_CR22","unstructured":"MedCalc. Comparison of proportions calculator [Internet]. [cited 2021 Jun 12]. https:\/\/www.medcalc.org\/calc\/comparison_of_proportions.php"},{"issue":"3","key":"6516_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.diabres.2008.01.009","volume":"80","author":"KZ Vardakas","year":"2008","unstructured":"Vardakas KZ, Horianopoulou M, Falagas ME. Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials. Diab Res Clin Pract. 2008;80(3):344\u201351.","journal-title":"Diab Res Clin Pract"},{"issue":"4","key":"6516_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1534734614550311","volume":"13","author":"B Zenelaj","year":"2014","unstructured":"Zenelaj B, Bouvet C, Uckay I, Lipsky BA. Do diabetic foot infections with methicillin-resistant staphylococcus aureus differ from those with other pathogens? Int J Low Extrem Wounds. 2014;13(4):263\u201372.","journal-title":"Int J Low Extrem Wounds"},{"issue":"6","key":"6516_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10096-014-2047-5","volume":"33","author":"M Hatipoglu","year":"2014","unstructured":"Hatipoglu M, Turhan V, Mutluoglu M, Uzun G, Karabacak E, Lipsky BA. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. Eur J Clin Microbiol Infect Dis. 2014;33(6):871\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"6516_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.ajic.2016.05.009","volume":"44","author":"J Cadena","year":"2016","unstructured":"Cadena J, Thinwa J, Walter EA, Frei CR. Risk factors for the development of active methicillin-resistant Staphylococcus aureus (MRSA) infection in patients colonized with MRSA at hospital admission. Am J Infect Control. 2016;44(12):1617\u201321.","journal-title":"Am J Infect Control"},{"issue":"3","key":"6516_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jdi.12591","volume":"8","author":"J Lin","year":"2017","unstructured":"Lin J, Xu P, Peng Y, Lin D, Ou Q, Zhang T, et al. Prevalence and characteristics of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus nasal colonization among a community-based diabetes population in Foshan, China. J Diab Investig. 2017;8(3):383\u201391.","journal-title":"J Diab Investig"},{"issue":"1","key":"6516_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00125-010-1893-7","volume":"54","author":"P Ramakant","year":"2011","unstructured":"Ramakant P, Verma AK, Chand G, Mishra A, Agarwal G, Agarwal A, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54(1):58\u201364.","journal-title":"Diabetologia"},{"issue":"1","key":"6516_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12866-016-0665-z","volume":"16","author":"K Smith","year":"2016","unstructured":"Smith K, Butcher J, MacKay WG, Williams C, Collier A, Bal AM, et al. One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers. BMC Microbiol. 2016;16(1):54.","journal-title":"BMC Microbiol"},{"key":"6516_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ebiom.2017.06.026","volume":"21","author":"M Malone","year":"2017","unstructured":"Malone M, Johani K, Hu H, Vickery K, Jensen SO, Gosbell IB, et al. Next generation DNA sequencing of tissues from infected diabetic foot ulcers. EBioMedicine. 2017;21:142\u20139.","journal-title":"EBioMedicine"},{"issue":"14","key":"6516_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2165\/11538070-000000000-00000","volume":"70","author":"I Eleftheriadou","year":"2010","unstructured":"Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70(14):1785\u201397.","journal-title":"Drugs"},{"issue":"7","key":"6516_CR32","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.12968\/jowc.2016.25.Sup7.S27","volume":"25","author":"R Fish","year":"2016","unstructured":"Fish R, Kutter E, Wheat G, Blasdel B, Kutateladze M, Kuhl S. Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. J Wound Care. 2016;25(7):S27-33.","journal-title":"J Wound Care"},{"key":"6516_CR33","doi-asserted-by":"publisher","first-page":"j5064","DOI":"10.1136\/bmj.j5064","volume":"359","author":"SC Mishra","year":"2017","unstructured":"Mishra SC, Chhatbar KC, Kashikar A, Mehndiratta A. Diabetic foot. BMJ. 2017;359:j5064.","journal-title":"BMJ"},{"key":"6516_CR34","unstructured":"University of York, Centre for Reviews and Dissemination. PROSPERO. [Internet]. [cited 2021 Aug 7].\u00a0 https:\/\/www.crd.york.ac.uk\/prospero\/."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06516-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T02:03:28Z","timestamp":1628474608000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6516"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06516-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"17 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"770"}}